Ogasawara T - Search Results

1

Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.

Saito T, Kanda Y, Kami M, Kato K, Shoji N, Kanai S, Ohnishi T, Kawano Y, Nakai K, Ogasawara T, Matsubara H, Makimoto A, Tanosaki R, Tobinai K, Wakasugi H, Takaue Y, Mineishi S. Saito T, et al. Among authors: ogasawara t. Clin Cancer Res. 2002 Apr;8(4):1014-20. Clin Cancer Res. 2002. PMID: 11948108 Clinical Trial.

2

Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases.

Ueda S, Miyamoto S, Kaida K, Chizuka A, Kojima R, Takano J, Ogasawara T, Miyamoto K, Miyakoshi S, Kanda Y. Ueda S, et al. Among authors: ogasawara t. J Infect Chemother. 2016 May;22(5):287-91. doi: 10.1016/j.jiac.2016.01.009. Epub 2016 Feb 19. J Infect Chemother. 2016. PMID: 26908230

3

Ogasawara T, Yasuyama M, Kawauchi K. Ogasawara T, et al. Am J Hematol. 2005 Jun;79(2):136-41. doi: 10.1002/ajh.20329. Am J Hematol. 2005. PMID: 15929101 Free article. Review.

4

[Successful treatment with azacitidine for a patient with relapsed myelodysplastic syndrome after cord blood transplantation].

Ueda S, Miyakoshi S, Chizuka A, Kojima R, Ogasawara T, Miyamoto K. Ueda S, et al. Among authors: ogasawara t. Rinsho Ketsueki. 2013 Dec;54(12):2177-81. Rinsho Ketsueki. 2013. PMID: 24452149 Japanese.

5

[Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].

Yasuyama M, Kawauchi K, Takei K, Ogasawara T, Ohkawa S. Yasuyama M, et al. Among authors: ogasawara t. Rinsho Ketsueki. 2004 Jan;45(1):66-71. Rinsho Ketsueki. 2004. PMID: 14999937 Japanese.

6

Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells.

Kawauchi K, Ogasawara T, Yasuyama M, Ohkawa Si. Kawauchi K, et al. Among authors: ogasawara t. Blood Cells Mol Dis. 2003 Jul-Aug;31(1):11-7. doi: 10.1016/s1079-9796(03)00070-6. Blood Cells Mol Dis. 2003. PMID: 12850478

7

Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL.

Marshall S, Nishimura N, Inoue N, Yamauchi H, Tsuyama N, Takeuchi K, Mishima Y, Yokoyama M, Ogasawara T, Mori N, Ogawa T, Sakura H, Terui Y. Marshall S, et al. Among authors: ogasawara t. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):162-169. doi: 10.1016/j.clml.2020.12.017. Epub 2020 Dec 23. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33483276 Free article.

8

Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance.

Yasuyama M, Ogasawara T, Otsuka K, Aiba M, Kawauchi K. Yasuyama M, et al. Among authors: ogasawara t. Hematol Rep. 2012 May 10;4(2):e11. doi: 10.4081/hr.2012.e11. Epub 2012 Jul 2. Hematol Rep. 2012. PMID: 22826793 Free PMC article.

9

[Successful long-term management with low-dose prednisolone in an adult patient with Diamond-Blackfan anemia].

Ogasawara T, Kawauchi K, Mori N, Sakura H, Katoh F, Kanno H, Ito E. Ogasawara T, et al. Rinsho Ketsueki. 2017;58(8):917-921. doi: 10.11406/rinketsu.58.917. Rinsho Ketsueki. 2017. PMID: 28883274 Japanese.

10

REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan.

Sakurai A, Marshall S, Ogasawara T, Ogasawara T, Aoka Y, Sakura H, Uchigata Y, Ogawa T. Sakurai A, et al. Among authors: ogasawara t. J Infect Chemother. 2022 Jul;28(7):943-947. doi: 10.1016/j.jiac.2022.03.029. Epub 2022 Apr 7. J Infect Chemother. 2022. PMID: 35414436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters